The Motley Fool

This Stock Soared 309% From Its 2022 Low -- 2 Reasons to Buy It Now, and 1 Reason to Stay Away

DoorDash stock peaked in 2021, plunged in 2022, and spent the last two years in recovery mode. DoorDash's business looks very strong right now, and it just achieved an important profitability ...
Forbes

Will GSK Stock Rebound To Its 2022 Highs Of $47?

GSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% decline over ...
The Motley Fool

This Magnificent Stock Is Up 370% From Its 2022 Low -- 2 Reasons to Buy It Now, and 1 Reason to Steer Clear

DoorDash's stock peaked during the tech frenzy in 2021, before plunging in 2022 during the S&P 500 bear market. Its stock has since soared by 370%, thanks to its rapidly expanding platform and growing ...
Forbes

Will Bristol Myers Squibb Stock Rebound To Its 2022 Highs Of $80?

GERMANY - 2024/03/03: In this photo illustration, the Bristol-Myers Squibb Company logo is seen displayed on a tablet. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images) ...